The postdoctoral training program takes advantage of the integrated strength of the Molecular Oncology Program of the DC Davis Cancer Center and the exceptional expertise and training records of the participating faculty members in the area of Oncogene Signals and Chromosome Biology. As this is a new application, we intentionally selected training in a focused area. Even so, the laboratory training provided by the 20 senior and junior participating faculty members cuts across disciplines including molecular biology, genetics, cell biology, tumor biology and toxicology as well as biotechnology in cancer diagnosis and therapeutics. A strong clinical research component at the Cancer Center will facilitate the translational aspect of this program. A director and two co-directors, with guidance and evaluation of trainees by the executive committee, will administer the program. Besides formal coursework in the responsible conduct of research and human subjects research, a rich and diverse array of seminars, conferences, and discussion groups are available, such as the Cancer Biology Seminar Series, the Cancer Crosstalks, the Annual Cancer Center Symposium, a molecular oncology journal club and the Clinical Cancer Research Seminar. There is also a Training Forum specifically designed for the T32 trainees, where they will present research progress and gain practical knowledge about grant writing, application for independent position etc. Upon completion of this training program, postdoctoral trainees should be prepared to take positions as junior faculty in academic or research institutions, biotechnology industries or government laboratories. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA108459-02
Application #
7280319
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M1))
Program Officer
Gorelic, Lester S
Project Start
2006-09-01
Project End
2011-08-31
Budget Start
2007-09-01
Budget End
2008-08-31
Support Year
2
Fiscal Year
2007
Total Cost
$211,416
Indirect Cost
Name
University of California Davis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Rowson-Hodel, A R; Wald, J H; Hatakeyama, J et al. (2018) Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer. Oncogene 37:197-207
Harris, Todd R; Kodani, Sean; Rand, Amy A et al. (2018) Celecoxib Does Not Protect against Fibrosis and Inflammation in a Carbon Tetrachloride-Induced Model of Liver Injury. Mol Pharmacol 94:834-841
Lucchesi, Christopher A; Zhang, Jin; Ma, Buyong et al. (2018) Disruption of the Rbm38-eIF4E complex with a synthetic peptide Pep8 increases p53 expression. Cancer Res :
Rand, Amy A; Helmer, Patrick O; Inceoglu, Bora et al. (2018) LC-MS/MS Analysis of the Epoxides and Diols Derived from the Endocannabinoid Arachidonoyl Ethanolamide. Methods Mol Biol 1730:123-133
Rand, Amy A; Barnych, Bogdan; Morisseau, Christophe et al. (2017) Cyclooxygenase-derived proangiogenic metabolites of epoxyeicosatrienoic acids. Proc Natl Acad Sci U S A 114:4370-4375
Barnych, Bogdan; Rand, Amy A; Cajka, Tomas et al. (2017) Synthesis of cyclooxygenase metabolites of 8,9-epoxyeicosatrienoic acid (EET): 11- and 15-hydroxy 8,9-EETs. Org Biomol Chem 15:4308-4313
Yang, Hee Jung; Zhang, Jin; Yan, Wensheng et al. (2017) Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner. Proc Natl Acad Sci U S A 114:11500-11505
Scharadin, Tiffany M; He, Wei; Yiannakou, Yianni et al. (2017) Synthesis and biochemical characterization of EGF receptor in a water-soluble membrane model system. PLoS One 12:e0177761
Chen, Kuang-Yui; Knoepfler, Paul S (2016) To CRISPR and beyond: the evolution of genome editing in stem cells. Regen Med 11:801-816
Zhang, Jin; Lucchesi, Christopher; Chen, Xinbin (2016) A new function for p53 tetramerization domain in cell fate control. Cell Cycle 15:2854-2855

Showing the most recent 10 out of 47 publications